Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | G469K |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF G469K is a hotspot mutation within the protein kinase domain of the Braf protein (UniProt.org). G469K has been identified in the scientific literature (PMID: 29325942, PMID: 30348504, PMID: 31015314), but has not been biochemically characterized, and therefore, its effect on Braf protein function is unknown (PubMed, May 2024). |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF G469X BRAF G469K |
Transcript | NM_004333.6 |
gDNA | chr7:g.140781602_140781603delGGinsAA |
cDNA | c.1405_1406delGGinsAA |
Protein | p.G469K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378470.1 | chr7:g.140778000_140778001delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_001378467.1 | chr7:g.140781611_140781612delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140781602_140781603delGGinsAA | c.1405_1406delGGinsAA | p.G469K | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|